SHC
Price
$18.29
Change
+$0.17 (+0.94%)
Updated
Oct 2, 11:09 AM (EDT)
Capitalization
5.27B
39 days until earnings call
Intraday BUY SELL Signals
XGN
Price
$7.93
Change
+$0.04 (+0.51%)
Updated
Oct 2, 11:11 AM (EDT)
Capitalization
205.43M
45 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SHC vs XGN

SHC vs XGN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
SHC vs. XGN commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SHC is a StrongBuy and XGN is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
SHC vs XGN: Fundamental Ratings
SHC
XGN
OUTLOOK RATING
1..100
6387
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
3599
PRICE GROWTH RATING
1..100
4435
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
24n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XGN's Valuation (31) in the null industry is somewhat better than the same rating for SHC (68). This means that XGN’s stock grew somewhat faster than SHC’s over the last 12 months.

XGN's Profit vs Risk Rating (100) in the null industry is in the same range as SHC (100). This means that XGN’s stock grew similarly to SHC’s over the last 12 months.

SHC's SMR Rating (35) in the null industry is somewhat better than the same rating for XGN (99). This means that SHC’s stock grew somewhat faster than XGN’s over the last 12 months.

XGN's Price Growth Rating (35) in the null industry is in the same range as SHC (44). This means that XGN’s stock grew similarly to SHC’s over the last 12 months.

SHC's P/E Growth Rating (99) in the null industry is in the same range as XGN (100). This means that SHC’s stock grew similarly to XGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SHCXGN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (SHC: $18.12 vs. XGN: $7.89)
Brand notoriety: SHC and XGN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SHC: 63% vs. XGN: 116%
Market capitalization -- SHC: $5.27B vs. XGN: $205.43M
SHC [@Medical Specialties] is valued at $5.27B. XGN’s [@Medical Specialties] market capitalization is $205.43M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical Specialties] industry is $20.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SHC’s FA Score shows that 0 FA rating(s) are green while XGN’s FA Score has 1 green FA rating(s).

  • SHC’s FA Score: 0 green, 5 red.
  • XGN’s FA Score: 1 green, 4 red.
According to our system of comparison, both SHC and XGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SHC’s TA Score shows that 3 TA indicator(s) are bullish while XGN’s TA Score has 3 bullish TA indicator(s).

  • SHC’s TA Score: 3 bullish, 5 bearish.
  • XGN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both SHC and XGN are a bad buy in the short-term.

Price Growth

SHC (@Medical Specialties) experienced а -1.79% price change this week, while XGN (@Medical Specialties) price change was -9.73% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.42%. For the same industry, the average monthly price growth was +3.09%, and the average quarterly price growth was +45.49%.

Reported Earning Dates

SHC is expected to report earnings on Nov 10, 2026.

XGN is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Medical Specialties (-3.42% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
SHC
Daily Signal:
Gain/Loss:
XGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FCG29.090.57
+2.00%
First Trust Natural Gas ETF (FCG)
SOFX7.020.11
+1.59%
Defiance Daily Target 2X Long SOFI ETF (SOFX)
IAUM41.590.17
+0.41%
iShares Gold Trust Micro ETF of Benef Interest (IAUM)
DIVG35.880.12
+0.33%
Invesco S&P 500 High Dividend Growers ETF (DIVG)
USEW55.33N/A
N/A
Cambria US EW ETF (USEW)

SHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, SHC has been loosely correlated with RVTY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SHC jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHC
1D Price
Change %
SHC100%
-2.00%
RVTY - SHC
53%
Loosely correlated
-2.51%
TMO - SHC
52%
Loosely correlated
-3.34%
CRL - SHC
52%
Loosely correlated
-2.77%
A - SHC
50%
Loosely correlated
-3.27%
MTD - SHC
49%
Loosely correlated
-1.97%
More

XGN and

Correlation & Price change

A.I.dvisor tells us that XGN and SHC have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XGN and SHC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XGN
1D Price
Change %
XGN100%
-2.95%
SHC - XGN
30%
Poorly correlated
-2.00%
NTRA - XGN
27%
Poorly correlated
-1.17%
QDEL - XGN
26%
Poorly correlated
-1.52%
MXCT - XGN
25%
Poorly correlated
-2.68%
GRAL - XGN
25%
Poorly correlated
-5.40%
More